MA06.03 Efficacy and Safety of Taletrectinib in Patients with ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II StudyGeoffrey Liu, Lyudmila Bazhenova, C.-M. Choi et al.|Journal of Thoracic Oncology|2024Cited by 4